학술논문

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer.
Document Type
Article
Source
Cancers; Jun2022, Vol. 14 Issue 12, p2963-N.PAG, 17p
Subject
THERAPEUTIC use of antineoplastic agents
STOMACH tumors
COMBINATION drug therapy
CANCER chemotherapy
TREATMENT effectiveness
CANCER patients
CISPLATIN
DRUGS
QUALITY of life
SURVIVAL analysis (Biometry)
OXALIPLATIN
PATIENT compliance
COMBINED modality therapy
DRUG side effects
DRUG toxicity
Language
ISSN
20726694
Abstract
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)